Skip to main content
. Author manuscript; available in PMC: 2007 Apr 10.
Published in final edited form as: Bone. 2005 Aug 30;38(1):74–84. doi: 10.1016/j.bone.2005.07.008

Fig. 1.

Fig. 1

Effects of netoglitazone (squares) and rosiglitazone (circles) treatment on (A) adipocyte number; (B) alkaline phosphatase enzyme activity; (C) extracellular calcium deposition by U-33/γ2 cells; (D) extracellular calcium deposition by U-33/c cells. Vertical lines indicate standard deviation (SD) calculated from triplicate treatments. *P < 0.05 compared to rosiglitazone.